Skip to main content
Erschienen in: Annals of Hematology 12/2017

17.09.2017 | Original Article

Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation

verfasst von: C. S. Michel, D. Teschner, E. M. Wagner, M. Theobald, Markus P. Radsak

Erschienen in: Annals of Hematology | Ausgabe 12/2017

Einloggen, um Zugang zu erhalten

Abstract

Infections and infectious complications are the major cause of morbidity and mortality in febrile neutropenic patients after autologous stem cell transplantation. Laboratory biomarkers are helpful for early identification of critically ill patients and optimal therapy management. Several studies in adult non-neutropenic patients proposed sTREM-1 as a superior biomarker for identification of septic patients as well as a predictor for survival in these patients compared with procalcitonin (PCT), C-reactive protein (CRP), or interleukin-8 (IL-8). Here, to assess the utility of PCT, CRP, IL-8, and sTREM-1 in febrile neutropenia, 44 patients presenting with febrile neutropenia after autologous stem cell transplantation were recruited in a single-center prospective pilot study. We analyzed PCT and CRP as well as IL-8 and sTREM-1 levels pre- and post-transplantation at defined time points. In 20 of 44 patients, concentration of sTREM-1 was under the detection level at appearance of febrile neutropenia. Mean levels of PCT, IL-8, and CRP were significantly increased in infections of critically ill patients who by dysfunction or failure of one or more organs/system depend on survival from advanced instruments of monitoring and therapy. However, all tested biomarkers could not distinguish between presence and absence of bloodstream infection. The combination of the biomarkers PCT and IL-8 achieved a high sensitivity of 90% and specificity of 74% for the identification of serious complications in febrile neutropenia, whereas the combination of CRP and PCT or IL-8 achieved a high sensitivity of 100%, but with the addition of a low specificity of 47or 41%. In conclusion, we found that the measurement of sTREM-1 concentration at presentation of febrile neutropenia is not useful to identify bacterial bloodstream infections and critically ill patients. PCT and IL-8 are useful biomarkers for the early identification of critically ill patients, compared to CRP and sTREM-1 in febrile neutropenia. PCT or IL-8 in combination with clinical parameters should be considered in routine measurement to identify critically ill patients as early as possible.
Literatur
1.
Zurück zum Zitat Jantunen E et al (2006) Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients. Eur J Haematol 76(3):245–250CrossRefPubMed Jantunen E et al (2006) Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients. Eur J Haematol 76(3):245–250CrossRefPubMed
2.
Zurück zum Zitat Klastersky J et al (2016) Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Ann Oncol 27(suppl 5):v111–v118CrossRefPubMed Klastersky J et al (2016) Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Ann Oncol 27(suppl 5):v111–v118CrossRefPubMed
3.
Zurück zum Zitat Klastersky J, Paesmans M (2013) The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients. Support Care Cancer 21(5):1487–1495CrossRefPubMed Klastersky J, Paesmans M (2013) The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients. Support Care Cancer 21(5):1487–1495CrossRefPubMed
4.
Zurück zum Zitat Wu CW et al (2015) Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis. Support Care Cancer 23(10):2863–2872CrossRefPubMed Wu CW et al (2015) Does procalcitonin, C-reactive protein, or interleukin-6 test have a role in the diagnosis of severe infection in patients with febrile neutropenia? A systematic review and meta-analysis. Support Care Cancer 23(10):2863–2872CrossRefPubMed
5.
Zurück zum Zitat Hochreiter M et al (2009) Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 13(3):R83CrossRefPubMedPubMedCentral Hochreiter M et al (2009) Procalcitonin to guide duration of antibiotic therapy in intensive care patients: a randomized prospective controlled trial. Crit Care 13(3):R83CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Nobre V et al (2008) Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 177(5):498–505CrossRefPubMed Nobre V et al (2008) Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med 177(5):498–505CrossRefPubMed
7.
Zurück zum Zitat Lima SS et al (2016) Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial. Ann Hematol 95(7):1169–1176CrossRefPubMed Lima SS et al (2016) Procalcitonin-guided protocol is not useful to manage antibiotic therapy in febrile neutropenia: a randomized controlled trial. Ann Hematol 95(7):1169–1176CrossRefPubMed
8.
Zurück zum Zitat Clec’h C et al (2004) Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 32(5):1166–1169CrossRefPubMed Clec’h C et al (2004) Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 32(5):1166–1169CrossRefPubMed
9.
Zurück zum Zitat Schneider CP et al (2009) Accuracy of procalcitonin for outcome prediction in unselected postoperative critically ill patients. Shock 31(6):568–573CrossRefPubMed Schneider CP et al (2009) Accuracy of procalcitonin for outcome prediction in unselected postoperative critically ill patients. Shock 31(6):568–573CrossRefPubMed
10.
Zurück zum Zitat Hatzistilianou M et al (2010) Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia. Inflamm Res 59(5):339–347CrossRefPubMed Hatzistilianou M et al (2010) Procalcitonin as an early marker of bacterial infection in neutropenic febrile children with acute lymphoblastic leukemia. Inflamm Res 59(5):339–347CrossRefPubMed
11.
Zurück zum Zitat Engel A et al (2005) Interleukin-8 serum levels at fever onset in patients with neutropenia predict early medical complications. Infection 33(5–6):380–382CrossRefPubMed Engel A et al (2005) Interleukin-8 serum levels at fever onset in patients with neutropenia predict early medical complications. Infection 33(5–6):380–382CrossRefPubMed
12.
Zurück zum Zitat Stryjewski GR et al (2005) Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med 6(2):129–135CrossRefPubMed Stryjewski GR et al (2005) Interleukin-6, interleukin-8, and a rapid and sensitive assay for calcitonin precursors for the determination of bacterial sepsis in febrile neutropenic children. Pediatr Crit Care Med 6(2):129–135CrossRefPubMed
13.
Zurück zum Zitat Miedema KG et al (2011) The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia. Support Care Cancer 19(10):1593–1600CrossRefPubMed Miedema KG et al (2011) The diagnostic value of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients with febrile neutropenia. Support Care Cancer 19(10):1593–1600CrossRefPubMed
14.
Zurück zum Zitat Bouchon A, Dietrich J, Colonna M (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164(10):4991–4995CrossRefPubMed Bouchon A, Dietrich J, Colonna M (2000) Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 164(10):4991–4995CrossRefPubMed
15.
Zurück zum Zitat Lemarie J, Barraud D, Gibot S (2015) Host response biomarkers in sepsis: overview on sTREM-1 detection. Methods Mol Biol 1237:225–239CrossRefPubMed Lemarie J, Barraud D, Gibot S (2015) Host response biomarkers in sepsis: overview on sTREM-1 detection. Methods Mol Biol 1237:225–239CrossRefPubMed
16.
Zurück zum Zitat Su L, Xie L, Liu D (2015) Urine sTREM-1 may be a valuable biomarker in diagnosis and prognosis of sepsis-associated acute kidney injury. Crit Care 19:281CrossRefPubMedPubMedCentral Su L, Xie L, Liu D (2015) Urine sTREM-1 may be a valuable biomarker in diagnosis and prognosis of sepsis-associated acute kidney injury. Crit Care 19:281CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Rohde G et al (2012) Levels of soluble triggering receptor expressed on myeloid cells 1 in infectious exacerbations of chronic obstructive pulmonary disease. Respiration 83(2):133–139CrossRefPubMed Rohde G et al (2012) Levels of soluble triggering receptor expressed on myeloid cells 1 in infectious exacerbations of chronic obstructive pulmonary disease. Respiration 83(2):133–139CrossRefPubMed
18.
Zurück zum Zitat Palazzo SJ, Simpson T, Schnapp LM (2012) Triggering receptor expressed on myeloid cells type 1 as a potential therapeutic target in sepsis. Dimens Crit Care Nurs 31(1):1–6CrossRefPubMedPubMedCentral Palazzo SJ, Simpson T, Schnapp LM (2012) Triggering receptor expressed on myeloid cells type 1 as a potential therapeutic target in sepsis. Dimens Crit Care Nurs 31(1):1–6CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Gomez-Pina V et al (2007) Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol 179(6):4065–4073CrossRefPubMed Gomez-Pina V et al (2007) Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol 179(6):4065–4073CrossRefPubMed
20.
Zurück zum Zitat Su L et al (2013) Diagnostic value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction. Mediat Inflamm 2013:969875 Su L et al (2013) Diagnostic value of dynamics serum sCD163, sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction. Mediat Inflamm 2013:969875
21.
Zurück zum Zitat Charles PE et al (2016) Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis. BMC Infect Dis 16(1):559CrossRefPubMedPubMedCentral Charles PE et al (2016) Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis. BMC Infect Dis 16(1):559CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Su L et al (2012) Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis 12:157CrossRefPubMedPubMedCentral Su L et al (2012) Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study. BMC Infect Dis 12:157CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Klastersky J et al (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18(16):3038–3051CrossRefPubMed Klastersky J et al (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18(16):3038–3051CrossRefPubMed
24.
Zurück zum Zitat Hasibeder A et al (2015) Evaluation and validation of the detection of soluble triggering receptor expressed on myeloid cells 1 by enzyme-linked immunosorbent assay. Sci Rep 5:15381CrossRefPubMedPubMedCentral Hasibeder A et al (2015) Evaluation and validation of the detection of soluble triggering receptor expressed on myeloid cells 1 by enzyme-linked immunosorbent assay. Sci Rep 5:15381CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Tromp YH et al (2009) The predictive value of interleukin-8 (IL-8) in hospitalised patients with fever and chemotherapy-induced neutropenia. Eur J Cancer 45(4):596–600CrossRefPubMed Tromp YH et al (2009) The predictive value of interleukin-8 (IL-8) in hospitalised patients with fever and chemotherapy-induced neutropenia. Eur J Cancer 45(4):596–600CrossRefPubMed
27.
Zurück zum Zitat Uys A et al (2007) Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10. Eur J Cancer Care (Engl) 16(6):475–483CrossRef Uys A et al (2007) Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and -10. Eur J Cancer Care (Engl) 16(6):475–483CrossRef
28.
Zurück zum Zitat Prat C et al (2008) Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma 49(9):1752–1761CrossRefPubMed Prat C et al (2008) Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia. Leuk Lymphoma 49(9):1752–1761CrossRefPubMed
29.
Zurück zum Zitat Meidani M et al (2013) Procalcitonin and quantitative C-reactive protein role in the early diagnosis of sepsis in patients with febrile neutropenia. South Asian J Cancer 2(4):216–219CrossRefPubMedPubMedCentral Meidani M et al (2013) Procalcitonin and quantitative C-reactive protein role in the early diagnosis of sepsis in patients with febrile neutropenia. South Asian J Cancer 2(4):216–219CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Kwofie L et al (2012) Evaluation of circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict risk profile, response to antimicrobial therapy, and development of complications in patients with chemotherapy-associated febrile neutropenia: a pilot study. Ann Hematol 91(4):605–611CrossRefPubMed Kwofie L et al (2012) Evaluation of circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict risk profile, response to antimicrobial therapy, and development of complications in patients with chemotherapy-associated febrile neutropenia: a pilot study. Ann Hematol 91(4):605–611CrossRefPubMed
31.
Zurück zum Zitat Reilly JP et al (2016) Neutropenic sepsis is associated with distinct clinical and biological characteristics: a cohort study of severe sepsis. Crit Care 20(1):222CrossRefPubMedPubMedCentral Reilly JP et al (2016) Neutropenic sepsis is associated with distinct clinical and biological characteristics: a cohort study of severe sepsis. Crit Care 20(1):222CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Klastersky J et al (2007) Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30(Suppl 1):S51–S59CrossRefPubMed Klastersky J et al (2007) Bacteraemia in febrile neutropenic cancer patients. Int J Antimicrob Agents 30(Suppl 1):S51–S59CrossRefPubMed
34.
Zurück zum Zitat Pinana JL et al (2014) Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients. Ann Hematol 93(2):299–307CrossRefPubMed Pinana JL et al (2014) Incidence, risk factors, and outcome of bacteremia following autologous hematopoietic stem cell transplantation in 720 adult patients. Ann Hematol 93(2):299–307CrossRefPubMed
35.
Zurück zum Zitat Rewa O et al (2012) Coagulase-negative Staphylococcus, catheter-related, bloodstream infections and their association with acute phase markers of inflammation in the intensive care unit: an observational study. Can J Infect Dis Med Microbiol 23(4):204–208PubMedPubMedCentral Rewa O et al (2012) Coagulase-negative Staphylococcus, catheter-related, bloodstream infections and their association with acute phase markers of inflammation in the intensive care unit: an observational study. Can J Infect Dis Med Microbiol 23(4):204–208PubMedPubMedCentral
Metadaten
Titel
Diagnostic value of sTREM-1, IL-8, PCT, and CRP in febrile neutropenia after autologous stem cell transplantation
verfasst von
C. S. Michel
D. Teschner
E. M. Wagner
M. Theobald
Markus P. Radsak
Publikationsdatum
17.09.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Annals of Hematology / Ausgabe 12/2017
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-017-3128-1

Weitere Artikel der Ausgabe 12/2017

Annals of Hematology 12/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.